1. Home
  2. SAGE vs AVNS Comparison

SAGE vs AVNS Comparison

Compare SAGE & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • AVNS
  • Stock Information
  • Founded
  • SAGE 2010
  • AVNS 2014
  • Country
  • SAGE United States
  • AVNS United States
  • Employees
  • SAGE N/A
  • AVNS N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • AVNS Industrial Specialties
  • Sector
  • SAGE Health Care
  • AVNS Health Care
  • Exchange
  • SAGE Nasdaq
  • AVNS Nasdaq
  • Market Cap
  • SAGE 571.7M
  • AVNS 591.9M
  • IPO Year
  • SAGE 2014
  • AVNS N/A
  • Fundamental
  • Price
  • SAGE $9.08
  • AVNS $12.47
  • Analyst Decision
  • SAGE Hold
  • AVNS
  • Analyst Count
  • SAGE 18
  • AVNS 0
  • Target Price
  • SAGE $10.06
  • AVNS N/A
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • AVNS 418.7K
  • Earning Date
  • SAGE 07-30-2025
  • AVNS 07-30-2025
  • Dividend Yield
  • SAGE N/A
  • AVNS N/A
  • EPS Growth
  • SAGE N/A
  • AVNS N/A
  • EPS
  • SAGE N/A
  • AVNS N/A
  • Revenue
  • SAGE $47,404,000.00
  • AVNS $689,200,000.00
  • Revenue This Year
  • SAGE $102.21
  • AVNS N/A
  • Revenue Next Year
  • SAGE $43.01
  • AVNS $3.42
  • P/E Ratio
  • SAGE N/A
  • AVNS N/A
  • Revenue Growth
  • SAGE N/A
  • AVNS 1.34
  • 52 Week Low
  • SAGE $4.62
  • AVNS $11.75
  • 52 Week High
  • SAGE $13.47
  • AVNS $25.36
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 71.54
  • AVNS 49.66
  • Support Level
  • SAGE $9.04
  • AVNS $12.00
  • Resistance Level
  • SAGE $9.30
  • AVNS $12.83
  • Average True Range (ATR)
  • SAGE 0.15
  • AVNS 0.31
  • MACD
  • SAGE 0.05
  • AVNS 0.04
  • Stochastic Oscillator
  • SAGE 91.35
  • AVNS 57.51

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: